131 related articles for article (PubMed ID: 3027466)
1. Autocrine growth of human B lymphocytes: maintained response to autostimulatory factors is the special feature of immortalization by Epstein-Barr virus--a hypothesis.
Gordon J; Guy G; Walker L; Nathan P; Exley R; Clemens M
Med Oncol Tumor Pharmacother; 1986; 3(3-4):269-73. PubMed ID: 3027466
[TBL] [Abstract][Full Text] [Related]
2. Soluble factor requirements for the autostimulatory growth of B lymphoblasts immortalized by Epstein-Barr virus.
Gordon J; Ley SC; Melamed MD; Aman P; Hughes-Jones NC
J Exp Med; 1984 May; 159(5):1554-9. PubMed ID: 6325575
[TBL] [Abstract][Full Text] [Related]
3. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells.
Tosato G; Tanner J; Jones KD; Revel M; Pike SE
J Virol; 1990 Jun; 64(6):3033-41. PubMed ID: 2159561
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
Tseng CT; Springgate CF; Piela TH; Choi YS
J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor.
Yokoi T; Miyawaki T; Yachie A; Kato K; Kasahara Y; Taniguchi N
Immunology; 1990 May; 70(1):100-5. PubMed ID: 2162322
[TBL] [Abstract][Full Text] [Related]
6. B cell-derived BCGF functions as autocrine growth factor(s) in normal and transformed B lymphocytes.
Muraguchi A; Nishimoto H; Kawamura N; Hori A; Kishimoto T
J Immunol; 1986 Jul; 137(1):179-86. PubMed ID: 3486912
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a human B cell line that proliferates in response to B cell growth factor.
Abe H; Rossio JL; Ruscetti FW; Matsushima K; Oppenheim JJ
J Immunol Methods; 1986 Jun; 90(1):111-23. PubMed ID: 2423613
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 1 alpha acts as an autocrine growth factor for RPMI 1788, an Epstein-Barr virus-transformed human B cell line.
Vandenabeele P; Jayaram B; Devos R; Shaw A; Fiers W
Eur J Immunol; 1988 Jul; 18(7):1027-31. PubMed ID: 2841138
[TBL] [Abstract][Full Text] [Related]
9. The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells.
Swendeman S; Thorley-Lawson DA
EMBO J; 1987 Jun; 6(6):1637-42. PubMed ID: 3038527
[TBL] [Abstract][Full Text] [Related]
10. Autocrine models of B-lymphocyte growth. I. Role of cell contact and soluble factors in T-independent B-cell responses.
Gordon J; Guy G; Walker L
Immunology; 1985 Oct; 56(2):329-35. PubMed ID: 2997026
[TBL] [Abstract][Full Text] [Related]
11. Self-stimulating growth factor production by B-cell lines derived from Burkitt's lymphomas and other lines transformed in vitro by Epstein-Barr virus.
Blazar BA; Sutton LM; Strome M
Cancer Res; 1983 Oct; 43(10):4562-8. PubMed ID: 6309371
[TBL] [Abstract][Full Text] [Related]
12. Synergistic activation of cells by Epstein-Barr virus and B-cell growth factor.
Hutt-Fletcher LM
J Virol; 1987 Mar; 61(3):774-81. PubMed ID: 3027404
[TBL] [Abstract][Full Text] [Related]
13. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2.
Wakasugi N; Tagaya Y; Wakasugi H; Mitsui A; Maeda M; Yodoi J; Tursz T
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8282-6. PubMed ID: 2172979
[TBL] [Abstract][Full Text] [Related]
14. Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines.
Estrov Z; Kurzrock R; Pocsik E; Pathak S; Kantarjian HM; Zipf TF; Harris D; Talpaz M; Aggarwal BB
J Exp Med; 1993 Mar; 177(3):763-74. PubMed ID: 8382256
[TBL] [Abstract][Full Text] [Related]
15. Autocrine models of B-lymphocyte growth. II. Interleukin-1 supports the proliferation of transformed lymphoblasts but not the stimulation of resting B cells triggered through their receptors for antigen.
Gordon J; Guy G; Walker L
Immunology; 1986 Mar; 57(3):419-23. PubMed ID: 3007333
[TBL] [Abstract][Full Text] [Related]
16. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM
Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047
[TBL] [Abstract][Full Text] [Related]
17. A major 50-kDa human B-cell growth factor-II induces both Tac antigen expression and proliferation by several types of lymphocytes.
Kawano M; Matsushima K; Masuda A; Oppenheim JJ
Cell Immunol; 1988 Feb; 111(2):273-86. PubMed ID: 2827895
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulating activity in supernatants from EBV immortalized lymphocytes.
Blazar BA; Sutton LM; Strome M
Cancer Immunol Immunother; 1986; 22(1):62-7. PubMed ID: 3011263
[TBL] [Abstract][Full Text] [Related]
19. The role of lactic acid in autocrine B-cell growth stimulation.
Pike SE; Markey SP; Ijames C; Jones KD; Tosato G
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11081-5. PubMed ID: 1662382
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E
Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
